
Bayer shares rise 11% after winning U.S. lawsuit over Roundup cancer case
CHICAGO, ILLINOIS – MAY 14: Products containing the herbicide Roundup remain available at a local home improvement store, despite legal challenges. On May 14, 2019, the day after a jury ordered Monsanto, now owned by Bayer, to pay a California couple more than $2 billion in Roundup-related cancer claims, Bayer’s stock appreciated significantly. Since acquiring Monsanto, Bayer has seen its stock price drop 40% due to ongoing litigation. Bayer shares rose sharply in early trading today after the company won a favorable verdict from a U.S. court over allegations that its widely used herbicide, Roundup, contributes to cancer. By the…








